Europe
Truffle Capital, founded in 2001 and based in Paris, is a venture capital firm that focuses on supporting start-ups in in life sciences and IT.
GlaxoSmithKline CEO Emma Walmsley is eying a big acquisition to spur revenue growth but is making sure that her company will not overpay.
GlaxoSmithKline CEO Emma Walmsley is not done reshaping her leadership team as she continues to overhaul the company’s pharmaceutical division.
In his opening presentation at JPM, he highlighted one major product to show how the Irish medtech company is pursuing value-based care.
Adaptimmune is making strides on becoming a fully integrated cell therapy company behind its T Cell Receptor technology
Since the acquisition fell apart, Allergan has fallen on some hard times.
Vivek Ramaswamy’s Axovant has egg on its face after it was forced to own up to the fact it misreported mid-stage data on a drug it hoped to take into Phase III.
Shire is splitting into two separate internal business units, Rare Disease Division and Neuroscience Division.
2017 was the second-best year for FDA approvals since 1996.
Will this new buy be enough for Celgene investors?
PRESS RELEASES